Mednet Logo
SpecialtiesCardiology
Cardiology

Cardiology

Expert discussions on heart failure, arrhythmias, interventional procedures, and cardiovascular risk management.

Recent Discussions

Are there other scenarios besides prior history of TIA or stroke or LV dysfunction in which systemic anticoagulation for LV non-compaction would be considered?

1 Answers

Mednet Member
Mednet Member
Cardiology · UC Davis

There is limited data in this area, but LV non-compaction by itself is not always an indication for anticoagulation. In addition to prior history of TIA, stroke or LV dysfunction, other conditions that anticoagulation should be considered include a history of atrial fibrillation or LV thrombus. The ...

When should you consider adding clonidine to an antihypertensive regimen for patients with advanced CKD?

1
2 Answers

Mednet Member
Mednet Member
Nephrology · Eastern Nephrology Associates

Clonidine patch is useful in severely uncontrolled hypertension. In patients with CKD, not responding to conventional medications - like calcium blockers. Though the side effect profile is not great, it is less expensive and practical.

What is your risk/benefit analysis when deciding on the appropriateness and timing for discontinuation of systemic anticoagulation in patients who underwent ablation for paroxysmal atrial fibrillation with CHADS2VASc score >2?

3
1 Answers

Mednet Member
Mednet Member
Cardiology · University of Arizona College of Medicine

I typically do not discontinue oral anticoagulation in post-ablation patients with paroxysmal atrial fibrillation and a CHA₂DS₂-VASc score of >2. Catheter ablation is not considered a "cure" for atrial fibrillation; therefore, there is always a risk of recurrent arrhythmia. The patient may be asympt...

What is a reasonable imaging modality for older patients with pAfib already on systemic anticoagulation outpatient but presenting with suspected cardioembolic stroke and TTE without evidence of LV thrombus?

3 Answers

Mednet Member
Mednet Member
Cardiology · The George Washington University Hospital

Gold standard is TEE.

What are first-line choices for vasopressors/inotropes to use in hypotensive patients with Eisenmenger Syndrome?

1 Answers

Mednet Member
Mednet Member
Cardiology · Nyu Langone Cardiology Associates

The answer is that it all depends on the etiology... However, a common issue with Eisenmenger syndrome (ES) is that routine pharmacological treatments that cause peripheral vasodilatation may worsen the right to left shunting and further shock. My first patient with ES was a gentleman recovering fro...

In a patient with known chronic LV thrombus and atrial fibrillation, is rhythm control still an option?

1 Answers

Mednet Member
Mednet Member
Cardiology · Lankenau Heart Group

I am not sure why it wouldn’t be. The decision to anticoagulate for a chronic thrombus is separate from an AF indication. As long as a left atrial (LA) clot is not present, one could argue that chronic anticoagulation will be a necessity whether the patient is converted to sinus rhythm or remains in...

What is your approach to the management of chronic GI bleeding from AVMs in an elderly patient on DOAC for atrial fibrillation?

6
7 Answers

Mednet Member
Mednet Member
Cardiology · University of California - Davis Health

I would definitely strongly consider the left atrial appendage occlusion device in these patients. While usually these devices (such as Watchman) do require anticoagulation for about 45 days until the device has an endothelial layer form on it (we usually confirm with a CT scan or TEE), there are so...

When would you consider starting lipid-lowering therapy for young adults < 30 years of age who have markedly elevated LP(a) and family history of elevated LP(a) and ischemic heart disease?

1 Answers

Mednet Member
Mednet Member
Cardiology · Ohio State University Cardiovascular Medicine

Years ago, there was a cartoon where two men were sitting eating dinner, and one said to the other, “My physician told me that worrying about your cholesterol was the leading cause of hypertension.” Our discussion question is appropriate given the recently released new guidelines for treating choles...

How does VExUS evaluation differ in a patient with a transjugular intrahepatic portosystemic shunt (TIPS)?

1 Answers

Mednet Member
Mednet Member
Hospital Medicine · Northwestern University

This is a very interesting question, and I don't think I have ever tried to look at VExUS in a patient with a TIPS before! Although, based on what I understand about this study, I would be cautious about relying on the original VExUS algorithm that incorporates hepatic vein, portal vein, and intrare...

Do you plan to incorporate fish-oil supplementation into the care of hemodialysis patients to reduce cardiovascular events in light of the PISCES trial results?

1
2 Answers

Mednet Member
Mednet Member
Nephrology · Rush Medical College

I showed the paper to an Internal Medicine friend of mine who is more statistically savvy than me. He wrote this: "So I read the study, and I’m still at a loss to understand it. I’m pretty Bayesian, but this study breaks my priors. Prior studies were basically negative, not to mention that nothing e...